Glycerophospholipids containing omega-3 and omega-6 fatty acids
A technology of glycerophospholipids and unsaturated fatty acids, which can be used in medical preparations containing active ingredients, food science, digestive system, etc., and can solve problems such as strong fishy smell
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0163] The preparation of pharmaceutical compositions is well known in the art and is described in numerous documents and reference works, see for example Gennaro A.R. ed. (1990) Remington's Pharmaceutical Sciences, Mack Publishing Company, Easton, Pennsylvania, especially pages 1521-1712 therein .
[0164] As a food additive, the preparation of the present invention can be used in the form of soft capsules, tablets, syrups or any other common dietary supplement delivery system.
[0165] As a functional food, the product of the present invention can be incorporated and used in various foods such as dairy products, ice cream, biscuits, soy products, pastries and breads, soy sauces, seasonings, oils and fats, margarines, sauces, cereals, Beverages and mixed drinks, infant formula, baby food (biscuits, purees and fruit purees, cereals), food bars, snacks, confectionery, chocolate products.
[0166] As a pharmaceutical product, the preparation of the present invention can be deli...
Embodiment 1
[0180] method
[0181] animals and feed
[0182] Male Wistar rats originating from the same population were obtained by Harlen. 50 rats were randomly divided into 5 feed supplement groups. In addition to normal feed, there were: (i) a group (MCT group) fed with 0.1g medium-chain triglyceride (MCT) / 1ml supplementary matrix; (ii) ) group fed 0.1 g DHA / EPA (20 / 30% total fatty acid composition, diluted with MCT, yielding 30% (w / w) LC-PUFA compound) triglycerides / 1 ml supplemented matrix (LC-PUFA group); ( iii) a group fed with 0.1 g of soybean lecithin-derived PS (20% SB-PS w / w) / 1 ml of supplemented matrix (SB-PS group); and (iv) fed with 0.1 g of PS-ω3 (20% PS W / W, 30% of total LC-PUFA composition) / l ml group supplemented with matrix (PS group). Supplemented matrix was stored at -20°C and rats were fed fresh portions daily. All supplements are processed to minimize fatty acid oxidation. Rats were given feed and water ad libitum. All rats were housed in a standard environmen...
Embodiment 2
[0203] Embodiment 2-PS-ω3 treats ADHD child
[0204]Attention-deficit / hyperactivity disorder (ADHD) comprises a broad group of behavioral and learning problems whose definition and diagnosis remain controversial [Kamper (2001) J. Pediatr. 139:173-4; Richardson et al. (2000) Prostaglandins Leukot. Essent . Fatty Acids, 63(1-2):79-87]. The etiology of ADHD is recognized to be complex and multifactorial. ADHD has traditionally been a diagnosis used to describe children who are inattentive, impulsive, and / or hyperactive. Roughly speaking, 20-25% of children with ADHD show a loss of one or more specific learning abilities in mathematics, reading or spelling [Barkley, R.A. (1990) Attenation-deficit hyperactivity disorder: a handbook for diagrzosts arld treatment . New York: Guilford Press]. Children with ADHD often have trouble learning and concentrating and can be disorganized, have poor self-discipline, and have low self-esteem. It is conservatively estimated that 3-5% of the ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com